Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 250 of 640

Advanced search

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances

Yahoo FinanceOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Overseas vaccines surge as Sinovac Biotech (SVA) boosts H1 sales

Stock TitanOriginal source

🇪🇺Aug 17Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Pneumonia heterogeneity based on lung microbiota signature to predict patients at risk and treatment response

CORDISOriginal source

🇨🇦Aug 17Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Lactated Ringer's Injection USP: Presence of Particulate Matter

Presence of particulate matter in affected lot

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Aug 17Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Cook Medical Hemospray Kit

A communication is being issued to customers to provide information to be included in an upcoming ch...

Health Canada Recalls and Safety AlertsOriginal source

🇺🇸Aug 17CROir.labcorp.comTier 3 · Secondary coverage

Labcorp to Host Investor Day on September 10, 2026

Labcorp Drug DevelopmentOriginal source

🌍Aug 17discoverynews.google.comTier 2 · Trade media

FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify

Fierce BiotechOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Sandoz announces collaboration agreement with Shanghai Henlius Biotech

PMLiVEOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech Announces 2026 Interim Results

The Manila TimesOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

IAG Cargo expands pharma network to Kuala Lumpur

The STAT Trade TimesOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

OS Therapies Reports Second Quarter 2026 Financials and Provides Business and Regulatory Updates

TradingViewOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs - ETON +44%, DXCM, ORKA, CON, ATAI

RTTNewsOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases

The Manila TimesOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Genscript Biotech (SEHK:1548) Stock Near Doubles As Losses Deepen

simplywall.stOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Monaco Asset Management SAM Invests $10.58 Million in BioMarin Pharmaceutical Inc. $BMRN

MarketBeatOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

A PET scan matched MRI in 93% of lesions—what comes next?

Stock TitanOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

China's Sichuan Kelun-Biotech swings to profit in H1 on new product approvals

TradingViewOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

ACT Brief: Data Standardization Bottleneck in Real-Time Monitoring, US Biotech FIH Trial Regulatory Frustration, and FDA Approval of Zenbexus for Multiple Myeloma

Applied Clinical Trials OnlineOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Rats, cockroaches in kitchens, expired meat, spoiled chicken: How safe is the food you eat?

The Times of IndiaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech Announces 2026 Interim Results

PR NewswireOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD

The Manila TimesOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Sichuan Kelun-Biotech Biopharmaceutical: Net profit surged to RMB388.0 million on strong sales and one-off gains, with robust pipeline progress

TradingViewOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Annexon (ANNX) Adds Dual Primary Endpoint in Phase 3 Trial, Refl

GuruFocusOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Zai Lab and Argenx announce results from Alkivia Phase 3 study

TipRanksOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

FULC: Merger forms a migraine-focused biotech with $245M financing and clinical milestones ahead

TradingViewOriginal source

🌍Aug 17Industryadial.comTier 1 · Company source

Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

Adial PharmaceuticalsOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Persistent Asset Partners Ltd Makes New $4.57 Million Investment in BioMarin Pharmaceutical Inc. $BMRN

MarketBeatOriginal source

🇯🇵Aug 17Industrynippon-shinyaku.co.jpTier 1 · Company source

「神戸営業所・阪神営業所」移転のお知らせ

Nippon Shinyaku NewsOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

EyePoint's DURAVYU Cut Treatment Burden 42%—What It Missed

Stock TitanOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD

finance.yahoo.comOriginal source

🌍Aug 17discoverynews.google.comTier 2 · Trade media

Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval

Pharmaceutical TechnologyOriginal source

🌍Aug 17discoverynews.google.comTier 2 · Trade media

Sandoz targets industry patent void with $322m Henlius deal

Pharmaceutical TechnologyOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Nashik: FDA Suspends Licences Of Three Hotels Over Food Safety, Hygiene Violations

Free Press JournalOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Chancellor Joan Gabel joins AI biotech startup board

The Pitt NewsOriginal source

🌍Aug 17discoverynews.google.comTier 2 · Trade media

Treating mechanisms, not symptoms: ALS R&D today

pharmaphorumOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

argenx reports positive Phase 3 ALKIVIA results

grafa.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Survival win for Tagrisso-Orpathys combo in resistant lung cancer

The Pharma LetterOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Fresenius Ventures launches $231m fund to back biopharma

BioXconomyOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Danish industry warns against state-built production of critical meds

The Pharma LetterOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Karnataka to put QR codes outside hotels, pharmacies for instant food safety complaints

Moneycontrol.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Why is Shanghai Henlius Biotech stock climbing today?

Investing.comOriginal source

🇺🇰Aug 17Researchpirbright.ac.ukTier 2 · Direct publisher

Pirbright scientists help launch next phase of Livestock Antibody Hub

The Pirbright Institute (Virology)Original source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

China’s pharma contractors rally on pushback to US supply chain pressure

South China Morning PostOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Patients Improved by Week 4 in Autoimmune Myositis—Then What?

Stock TitanOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

Business WireOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Sun Pharmaceutical Industries shares fall 2.02%; stock among top losers on Nifty 50

Moneycontrol.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Mahama unveils 5-year drugs production plan - Targets 70% pharmaceutical import cut

Graphic OnlineOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Scottish Biotech Accelerator Opens for Applications

digit.fyiOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review

WSJOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Funding boost to help bio-based innovations reach market

Scientist LiveOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Biotech funding rises 75% this year as M&A activity continues

Investing.comOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Biotech funding rises 75% this year as M&A activity continues By Investing.com

Investing.com IndiaOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

ARGX Looks 41.1% Undervalued on GF Value™ After Vyvgart Phase 3 Success

GuruFocusOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Cullinan Therapeutics (CGEM) Advances in Phase 3 Trial, Shares Near 2-Year High Amid Mixed Signals

GuruFocusOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

CRA looking into pharmaceutical giant Eli Lilly Canada's taxes

unpublished.caOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Ruth Cheng leads the largest biological repository in the world

The Business JournalsOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Guilin Sanjin Pharmaceutical Co., Ltd. Class A – SZSE:002275

TradingViewOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

AstraZeneca (AZN) Stock Climbs on Promising Enhertu Cancer Trial Data

BlockonomiOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe, food safety boss, gets a shoutout from Mumbai civic chief

The Indian ExpressOriginal source

🌍Aug 17discoverynews.google.comTier 3 · Aggregated media

CSPC Innovation Pharmaceutical H1 Net Profit 1.3 Billion Yuan

TradingViewOriginal source